SHEL.UK

3,063

+1.32%↑

BP

477.35

+0.54%↑

REN

29.22

+2.38%↑

SDR

585.5

0%↓

SHEL.UK

3,063

+1.32%↑

BP

477.35

+0.54%↑

REN

29.22

+2.38%↑

SDR

585.5

0%↓

SHEL.UK

3,063

+1.32%↑

BP

477.35

+0.54%↑

REN

29.22

+2.38%↑

SDR

585.5

0%↓

SHEL.UK

3,063

+1.32%↑

BP

477.35

+0.54%↑

REN

29.22

+2.38%↑

SDR

585.5

0%↓

SHEL.UK

3,063

+1.32%↑

BP

477.35

+0.54%↑

REN

29.22

+2.38%↑

SDR

585.5

0%↓

Search

Smith & Nephew PLC

Затворен

1,369 1.33

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1367.5

Максимум

1372

Ключови измерители

By Trading Economics

Приходи

296M

Продажби

3B

P/E

Средно за сектора

32.689

49.134

EPS

0.429

Дивидентна доходност

2.85

Марж на печалбата

9.895

Служители

17,000

EBITDA

723M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+8.68% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.85%

3.77%

Следващи печалби

2.03.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

11B

Предишно отваряне

1367.67

Предишно затваряне

1369

Smith & Nephew PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

27.02.2026 г., 23:53 ч. UTC

Горещи акции

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27.02.2026 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

28.02.2026 г., 21:36 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28.02.2026 г., 15:20 ч. UTC

Печалби

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- 2nd Update

28.02.2026 г., 14:43 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28.02.2026 г., 14:38 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- Update

28.02.2026 г., 13:47 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28.02.2026 г., 13:44 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Berkshire Hathaway Earnings Slip on Decline in Insurance Results -- WSJ

28.02.2026 г., 13:14 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28.02.2026 г., 02:32 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Calpers Buys Into Hot Chip And Quantum Stocks -- Barrons.com

28.02.2026 г., 02:00 ч. UTC

Придобивния, сливания и поглъщания

Six Months, 9 Offers and $81 Billion. How Hollywood's Nasty Takeover Was Won. -- WSJ

28.02.2026 г., 02:00 ч. UTC

Придобивния, сливания и поглъщания

Six Months, 9 Offers and $81 Billion. How -2-

28.02.2026 г., 00:01 ч. UTC

Придобивния, сливания и поглъщания

Paramount Issuing $47 Billion of Equity at Big Premium to Stock Price for Warner Bros. Deal -- Barrons.com

27.02.2026 г., 23:46 ч. UTC

Придобивния, сливания и поглъщания

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27.02.2026 г., 23:33 ч. UTC

Придобивния, сливания и поглъщания

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27.02.2026 г., 21:50 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

27.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

27.02.2026 г., 21:30 ч. UTC

Печалби

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27.02.2026 г., 21:30 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27.02.2026 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27.02.2026 г., 21:17 ч. UTC

Печалби

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27.02.2026 г., 21:10 ч. UTC

Придобивния, сливания и поглъщания

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27.02.2026 г., 21:09 ч. UTC

Придобивния, сливания и поглъщания

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27.02.2026 г., 21:00 ч. UTC

Печалби

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27.02.2026 г., 20:31 ч. UTC

Придобивния, сливания и поглъщания

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27.02.2026 г., 20:24 ч. UTC

Пазарно говорене

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27.02.2026 г., 20:23 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27.02.2026 г., 20:12 ч. UTC

Пазарно говорене

Nike Seen With Further Challenges in China -- Market Talk

27.02.2026 г., 19:44 ч. UTC

Пазарно говорене

Gold Caps Historic Month -- Market Talk

27.02.2026 г., 19:39 ч. UTC

Печалби

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Smith & Nephew PLC Прогноза

Ценова цел

By TipRanks

8.68% нагоре

12-месечна прогноза

Среден 1,490.57 GBX  8.68%

Висок 1,650 GBX

Нисък 1,290 GBX

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Smith & Nephew PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

7 ratings

5

Купи

2

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat